Cognitive Impairment, Dementia and Alzheimer's Disease

Submission deadline: 31 August 2023
Special Issue Editors
  • Ioannis Liampas, MD, MSc
    Department of Neurology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, Larissa, Greece
    Interests: Transient Global Amnesia; Anterograde Amnesia; Forgetting; Migraine Disorders; Patent Foramen Ovale; Spreading Cortical Depression; Vitamin D; Fibromyalgia; Migraine Disorders
  • Efthimios Dardiotis, MD, PhD
    Department of Neurology, Laboratory of Neurogenetics, University Hospital of Larissa, Larissa, Greece; Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
    Interests: neuroscience; neurology; genetics association studies; genetic epidemiological studies; neuroimmunology; neurorehabilitation; neurodegenerative diseases
    Special Issues and Topics in IMR Press journals
Special Issue Information

Dear Colleagues,

Ageing is considered to be the strongest risk factor for dementia. As the world population ages, the prevalence of dementia has increased to unprecedented levels. The dramatic increase in the incidence of dementia along with its significant socioeconomic implications have expedited research in this field. Alzheimer’s disease (AD) constitutes the number one cause of dementia and is a major focus of global research. Important developments in dementia and AD are constantly being reported and new promising treatments for AD are being evaluated.

The borders between health and disease become more and more vague with increasing chronological age. Cognitive decline tends to accompany normal ageing, while functional impairments and neuropsychiatric manifestations are strongly related to cognitive deficits during senescence. Cognitive impairment has serious individual and social ramifications in both dementia and the normal ageing process. Therefore, a growing body of research has focused on the efficacious management and prevention of cognitive decline in older adults without full-blown dementia.

This Special Issue aims to review the newest advancements in the fields of dementia and cognitive decline in older adults. All types of manuscripts, including original research articles, reviews, systematic reviews and meta-analyses pertaining to these topics are welcomed by the Journal.

Dr. Ioannis Liampas and Dr. Efthimios Dardiotis
Guest Editors

Alzheimer’s disease
mild cognitive impairment
cognitive decline
neuropsychiatric symptoms
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (1 Paper)
Back to top